
The new site will expand research capabilities across immunology, neuroscience and oncology

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

The results from a global phase 3 trial show the longest survival data ever reported in this setting

Rinvoq is the first and only systemic medication approved in the EU for NSV

The acquisition includes clinical-stage candidates for atopic dermatitis and asthma

Spanning four dimensions of skin health, the framework introduces 15 terms and definitions

The pharma company has also pledged a $100bn investment in US infrastructure over the next decade

Lung cancer is the leading cause of cancer-related deaths worldwide

Approximately 226,650 lung cancer cases are expected to be diagnosed in the US this year

Follicular lymphoma affects around 15,000 people in the US every year

Around 700,000 people in the US are living with some form of the autoimmune disease

Non-small cell lung cancer accounts for up to 90% of all lung cancer cases